An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? | Zendy

Sara Bigliardi | Zendy; Monica Morselli | Zendy; Leonardo Potenza | Zendy; Paola Bresciani | Zendy; Aurora Cuoghi | Zendy; Valeria Coluccio | Zendy; Giovanni Riva | Zendy; Ambra Paolini | Zendy; Valeria Fantuzzi | Zendy; Laura Faglioni | Zendy; Vincenzo Nasillo | Zendy; Andrea Messerotti | Zendy; Roberto Marasca | Zendy; Franco Narni | Zendy; Mario Luppi | Zendy; Fabio Forghieri | Zendy

Open Access

An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells?

Author(s) -

Sara Bigliardi,

Monica Morselli,

Leonardo Potenza,

Paola Bresciani,

Aurora Cuoghi,

Valeria Coluccio,

Giovanni Riva,

Ambra Paolini,

Valeria Fantuzzi,

Laura Faglioni,

Vincenzo Nasillo,

Andrea Messerotti,

Roberto Marasca,

Franco Narni,

Mario Luppi,

Fabio Forghieri

Publication year - 2014

Publication title -

bone marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.609

H-Index - 127

eISSN - 1476-5365

pISSN - 0268-3369

DOI - 10.1038/bmt.2014.119

Subject(s) - medicine , acute promyelocytic leukemia , haematopoiesis , leukemia , oncology , stem cell , retinoic acid , genetics , cell culture , biology

We read with interest the recent article by Shiozaki H, et al. (Bone Marrow Transplant 2014; 49: 102–109) reporting a case of donor cell leukemia (DCL) occurring in a patient who previously underwent cord blood (CB) transplantation for myelodysplastic syndrome and describing the clinical and biological differences between DCL arising after hematopoietic SCT (HSCT) from either CB or BM sources. We would like to comment on these issues, reporting an unusual case of DCL in a patient with a long history of acute promyelocytic leukemia (APL)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research